Membrane lipid peroxidation (MLP) in Alzheimer's (AD) and Parkinson's (PD) brains and role of protease-activated receptor-1 (PAR-1).

被引:0
|
作者
Ameenuddin, JS
Landis, M
SantaCruz, KS
Festoff, BW
机构
[1] Vet Adm Med Ctr, Neurobiol Res Lab, Kansas City, MO 64128 USA
[2] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66170 USA
[3] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66170 USA
[4] Univ Kansas, Med Ctr, Dept Pharmacol, Kansas City, KS 66170 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S17 / S17
页数:1
相关论文
共 50 条
  • [41] Thrombin-induced Ca2+ mobilization in human gingival fibroblasts is mediated by protease-activated receptor-1 (PAR-1)
    Tanaka, N
    Morita, T
    Nezu, A
    Tanimura, A
    Mizoguchi, I
    Tojyo, Y
    LIFE SCIENCES, 2003, 73 (03) : 301 - 310
  • [42] Activation of rat mast cells upon stimulation of protease-activated receptor (PAR-1)
    Umarova, BA
    Dugina, TN
    Shestakova, EV
    Gluza, E
    Strukova, SM
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 129 (04) : 314 - 317
  • [43] Membrane lipid peroxidation in neurodegeneration: Role of thrombin and proteinase-activated receptor-1
    Citron, Bruce A.
    Ameenuddin, Syed
    Uchida, K.
    Suo, William Z.
    SantaCruz, Karen
    Festoff, Barry W.
    BRAIN RESEARCH, 2016, 1643 : 10 - 17
  • [44] Pharmacodynamics and pharmacokinetics of a novel protease-activated receptor (PAR-1) antagonist SCH 530348
    Kosoglou, T
    Reyderman, L
    Fales, RR
    Yang, B
    Keller, R
    Shah, A
    Maxwell, SE
    Veltri, EP
    Cutler, DL
    CIRCULATION, 2005, 112 (17) : U80 - U80
  • [45] In vivo and in vitro effect of a new thrombin protease-activated receptor (PAR-1) antagonist
    Dumas, M.
    Nadal-Wollbold, F.
    Grelac, F.
    Aiach, M.
    Le Grand, B.
    Gaussem, P.
    Bachelot-Loza, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 86 - 86
  • [46] Interaction of zyxin with protease-activated receptor-1: Role in thrombin signaling
    Han, Jingyan
    Liu, Guoquan
    Voyno-Yasenetskaya, Tatyana
    CIRCULATION, 2006, 114 (18) : 317 - 317
  • [47] SCH 530348 Is a Novel Oral Antiplatelet Agent Selective for Protease-Activated Receptor-1 (PAR-1) Receptor Subtype Without Partial Agonist Activity
    Chintala, Madhu
    Kurowski, Stan
    Zhai, Ying
    Lachowicz, Jean
    FASEB JOURNAL, 2009, 23
  • [48] Role of ubiquitination in the regulation of protease-activated receptor-1 signaling and trafficking
    Wolfe, BL
    Trejo, J
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 436A - 436A
  • [49] Doxorubicin-induced Cardiac and Hepatic Toxicity is Mediated by Protease-activated Receptor 1 (PAR-1)
    Antoniak, Silvio
    Pawlinski, Rafal
    Mackman, Nigel
    CIRCULATION, 2010, 122 (21)
  • [50] Autoimmune Targeting of Protease Activated Receptor-1 (PAR-1) Deregulates VEGF and Disturbs Neoangiogenesis.
    Catar, R.
    Schramm, I.
    Simon, M.
    Wischnewski, O.
    Philippe, A.
    Kusch, A.
    Dragun, D.
    TRANSPLANTATION, 2014, 98 : 382 - 382